Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Product Adoption / Usage Analysis
4.2. Product Features/ USPs
4.3. Breast Cancer Disease Epidemiology
4.4. Reimbursement Scenario
4.5. Regulatory Landscape
4.6. PESTEL Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure Outlook
5.1.2. Global Life Expectancy Outlook
5.1.3. Global Cancer Diagnostics Market Overview
5.2. Forecast Factors - Relevance & Impact
5.2.1. Key Player’s Historic Growth
5.2.2. Increasing prevalence of Cancer
5.2.3. Growing Awareness and Adoption of Breast Cancer Screening Tests
5.2.4. Treatment Seeking Population
5.2.5. Growing Product Approvals
5.2.6. Rising Number of Diagnostic Centres
5.2.7. Research and Development Expenditure by Key Players
5.3. Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
6.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Diagnostic Test Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Million) Analysis By Diagnostic Test Type, 2017 to 2022
7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Diagnostic Test Type, 2023 to 2033
7.3.1. Blood Marker Tests
7.3.2. Imaging Test Primary Cell-based Therapeutics
7.3.2.1. Mammography
7.3.2.2. MRI screening test
7.3.2.3. Molecular Breast Imaging Test
7.3.2.4. PET scan
7.3.2.5. Ultrasound
7.3.3. Genetic Test
7.3.3.1. Fluorescence In Situ Hybridization
7.3.3.2. HER gene test
7.3.4. Immunohistochemistry Test
7.4. Market Attractiveness Analysis By Diagnostic Test Type
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
8.3.1. Hospitals
8.3.2. Diagnostic Centres
8.3.3. Cancer Institutes
8.3.4. Research Laboratories
8.4. Market Attractiveness Analysis By End User
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
9.1. Introduction
9.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. South Asia
9.3.5. East Asia
9.3.6. Oceania
9.3.7. Middle East and Africa (MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
10.3.1. By Country
10.3.1.1. U.S.
10.3.1.2. Canada
10.3.2. By Diagnostic Test Type
10.3.3. By End User
10.4. Market Attractiveness Analysis
10.4.1. By Country
10.4.2. By Diagnostic Test Type
10.4.3. By End User
10.5. Country Level Analysis & Forecast
10.5.1. U.S. Market Analysis
10.5.1.1. .Introduction
10.5.1.2. Market Analysis and Forecast by Market Taxonomy
10.5.1.2.1. By Diagnostic Test Type
10.5.1.2.2. By End User
10.5.2. Canada Market Analysis
10.5.2.1. Introduction
10.5.2.2. Market Analysis and Forecast by Market Taxonomy
10.5.2.2.1. By Diagnostic Test Type
10.5.2.2.2. By End User
10.6. Market Trends
10.7. Key Market Participants - Intensity Mapping
10.8. Drivers and Restraints - Impact Analysis
11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
11.1. Introduction
11.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Argentina
11.3.1.4. Rest of Latin America
11.3.2. By Diagnostic Test Type
11.3.3. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Diagnostic Test Type
11.4.3. By End User
11.5. Country Level Analysis & Forecast
11.5.1. Brazil Market Analysis
11.5.1.1. .Introduction
11.5.1.2. Market Analysis and Forecast by Market Taxonomy
11.5.1.2.1. By Diagnostic Test Type
11.5.1.2.2. By End User
11.5.2. Mexico Market Analysis
11.5.2.1. Introduction
11.5.2.2. Market Analysis and Forecast by Market Taxonomy
11.5.2.2.1. By Diagnostic Test Type
11.5.2.2.2. By End User
11.5.3. Argentina Market Analysis
11.5.3.1. Introduction
11.5.3.2. Market Analysis and Forecast by Market Taxonomy
11.5.3.2.1. By Diagnostic Test Type
11.5.3.2.2. By End User
11.6. Market Trends
11.7. Key Market Participants - Intensity Mapping
11.8. Drivers and Restraints - Impact Analysis
12. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. France
12.3.1.3. Italy
12.3.1.4. U.K.
12.3.1.5. Spain
12.3.1.6. Russia
12.3.1.7. BENELUX
12.3.1.8. Rest of Europe
12.3.2. By Diagnostic Test Type
12.3.3. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Diagnostic Test Type
12.4.3. By End User
12.5. Country Level Analysis & Forecast
12.5.1. Germany Market Analysis
12.5.1.1. .Introduction
12.5.1.2. Market Analysis and Forecast by Market Taxonomy
12.5.1.2.1. By Diagnostic Test Type
12.5.1.2.2. By End User
12.5.2. France Market Analysis
12.5.2.1. Introduction
12.5.2.2. Market Analysis and Forecast by Market Taxonomy
12.5.2.2.1. By Diagnostic Test Type
12.5.2.2.2. By End User
12.5.3. Italy Market Analysis
12.5.3.1. Introduction
12.5.3.2. Market Analysis and Forecast by Market Taxonomy
12.5.3.2.1. By Diagnostic Test Type
12.5.3.2.2. By End User
12.5.4. U.K. Market Analysis
12.5.4.1. .Introduction
12.5.4.2. Market Analysis and Forecast by Market Taxonomy
12.5.4.2.1. By Diagnostic Test Type
12.5.4.2.2. By End User
12.5.5. Spain Market Analysis
12.5.5.1. .Introduction
12.5.5.2. Market Analysis and Forecast by Market Taxonomy
12.5.5.2.1. By Diagnostic Test Type
12.5.5.2.2. By End User
12.5.6. Russia Market Analysis
12.5.6.1. .Introduction
12.5.6.2. Market Analysis and Forecast by Market Taxonomy
12.5.6.2.1. By Diagnostic Test Type
12.5.6.2.2. By End User
12.5.7. BENELUX Market Analysis
12.5.7.1. .Introduction
12.5.7.2. Market Analysis and Forecast by Market Taxonomy
12.5.7.2.1. By Diagnostic Test Type
12.5.7.2.2. By End User
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
13. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. India
13.3.1.2. Thailand
13.3.1.3. Indonesia
13.3.1.4. Malaysia
13.3.1.5. Rest of South Asia
13.3.2. By Diagnostic Test Type
13.3.3. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Diagnostic Test Type
13.4.3. By End User
13.5. Country Level Analysis & Forecast
13.5.1. India Market Analysis
13.5.1.1. .Introduction
13.5.1.2. Market Analysis and Forecast by Market Taxonomy
13.5.1.2.1. By Diagnostic Test Type
13.5.1.2.2. By End User
13.5.2. Thailand Market Analysis
13.5.2.1. .Introduction
13.5.2.2. Market Analysis and Forecast by Market Taxonomy
13.5.2.2.1. By Diagnostic Test Type
13.5.2.2.2. By End User
13.5.3. Indonesia Market Analysis
13.5.3.1. Introduction
13.5.3.2. Market Analysis and Forecast by Market Taxonomy
13.5.3.2.1. By Diagnostic Test Type
13.5.3.2.2. By End User
13.5.4. Malaysia Market Analysis
13.5.4.1. Introduction
13.5.4.2. Market Analysis and Forecast by Market Taxonomy
13.5.4.2.1. By Diagnostic Test Type
13.5.4.2.2. By End User
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. By Diagnostic Test Type
14.3.3. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Diagnostic Test Type
14.4.3. By End User
14.5. Country Level Analysis & Forecast
14.5.1. China Market Analysis
14.5.1.1. .Introduction
14.5.1.2. Market Analysis and Forecast by Market Taxonomy
14.5.1.2.1. By Diagnostic Test Type
14.5.1.2.2. By End User
14.5.2. Japan Market Analysis
14.5.2.1. Introduction
14.5.2.2. Market Analysis and Forecast by Market Taxonomy
14.5.2.2.1. By Diagnostic Test Type
14.5.2.2.2. By End User
14.5.3. South Korea Market Analysis
14.5.3.1. Introduction
14.5.3.2. Market Analysis and Forecast by Market Taxonomy
14.5.3.2.1. By Diagnostic Test Type
14.5.3.2.2. By End User
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. Australia
15.3.1.2. New Zealand
15.3.2. By Diagnostic Test Type
15.3.3. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Diagnostic Test Type
15.4.3. By End User
15.5. Country Level Analysis & Forecast
15.5.1. Australia Market Analysis
15.5.1.1. .Introduction
15.5.1.2. Market Analysis and Forecast by Market Taxonomy
15.5.1.2.1. By Diagnostic Test Type
15.5.1.2.2. By End User
15.5.2. New Zealand Market Analysis
15.5.2.1. Introduction
15.5.2.2. Market Analysis and Forecast by Market Taxonomy
15.5.2.2.1. By Diagnostic Test Type
15.5.2.2.2. By End User
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. GCC Countries
16.3.1.2. Türkiye
16.3.1.3. Northern Africa
16.3.1.4. South Africa
16.3.1.5. Rest of Middle East and Africa
16.3.2. By Diagnostic Test Type
16.3.3. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Diagnostic Test Type
16.4.3. By End User
16.5. Country Level Analysis & Forecast
16.5.1. GCC Countries Market Analysis
16.5.1.1. .Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Diagnostic Test Type
16.5.1.2.2. By End User
16.5.2. Türkiye Market Analysis
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Diagnostic Test Type
16.5.2.2.2. By End User
16.5.3. Northern Africa Market Analysis
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Diagnostic Test Type
16.5.3.2.2. By End User
16.5.4. South Africa Market Analysis
16.5.4.1. Introduction
16.5.4.2. Market Analysis and Forecast by Market Taxonomy
16.5.4.2.1. By Diagnostic Test Type
16.5.4.2.2. By End User
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Market Structure Analysis
17.1. Market Analysis by Tier of Companies
17.2. Market Share Analysis of Top Players
17.3. Market Presence Analysis
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
18.3.1. AstraZeneca
18.3.1.1. Overview
18.3.1.2. Product Portfolio
18.3.1.3. Key Financials
18.3.1.4. Sales Footprint
18.3.1.5. SWOT Analysis
18.3.1.6. Strategy Overview
18.3.1.6.1. Marketing Strategy
18.3.1.6.2. Product Strategy
18.3.1.6.3. Channel Strategy
18.3.2. Novartis
18.3.2.1. Overview
18.3.2.2. Product Portfolio
18.3.2.3. Key Financials
18.3.2.4. Sales Footprint
18.3.2.5. SWOT Analysis
18.3.2.6. Strategy Overview
18.3.2.6.1. Marketing Strategy
18.3.2.6.2. Product Strategy
18.3.2.6.3. Channel Strategy
18.3.3. Sanofi
18.3.3.1. Overview
18.3.3.2. Product Portfolio
18.3.3.3. Key Financials
18.3.3.4. Sales Footprint
18.3.3.5. SWOT Analysis
18.3.3.6. Strategy Overview
18.3.3.6.1. Marketing Strategy
18.3.3.6.2. Product Strategy
18.3.3.6.3. Channel Strategy
18.3.4. Pfizer
18.3.4.1. Overview
18.3.4.2. Product Portfolio
18.3.4.3. Key Financials
18.3.4.4. Sales Footprint
18.3.4.5. SWOT Analysis
18.3.4.6. Strategy Overview
18.3.4.6.1. Marketing Strategy
18.3.4.6.2. Product Strategy
18.3.4.6.3. Channel Strategy
18.3.5. Bayer AG
18.3.5.1. Overview
18.3.5.2. Product Portfolio
18.3.5.3. Key Financials
18.3.5.4. Sales Footprint
18.3.5.5. SWOT Analysis
18.3.5.6. Strategy Overview
18.3.5.6.1. Marketing Strategy
18.3.5.6.2. Product Strategy
18.3.5.6.3. Channel Strategy
18.3.6. GlaxoSmithKline plc
18.3.6.1. Overview
18.3.6.2. Product Portfolio
18.3.6.3. Key Financials
18.3.6.4. Sales Footprint
18.3.6.5. SWOT Analysis
18.3.6.6. Strategy Overview
18.3.6.6.1. Marketing Strategy
18.3.6.6.2. Product Strategy
18.3.6.6.3. Channel Strategy
18.3.7. Siemens Healthineers
18.3.7.1. Overview
18.3.7.2. Product Portfolio
18.3.7.3. Key Financials
18.3.7.4. Sales Footprint
18.3.7.5. SWOT Analysis
18.3.7.6. Strategy Overview
18.3.7.6.1. Marketing Strategy
18.3.7.6.2. Product Strategy
18.3.7.6.3. Channel Strategy
18.3.8. Hologic Inc.
18.3.8.1. Overview
18.3.8.2. Product Portfolio
18.3.8.3. Key Financials
18.3.8.4. Sales Footprint
18.3.8.5. SWOT Analysis
18.3.8.6. Strategy Overview
18.3.8.6.1. Marketing Strategy
18.3.8.6.2. Product Strategy
18.3.8.6.3. Channel Strategy
18.3.9. General Electric Company
18.3.9.1. Overview
18.3.9.2. Product Portfolio
18.3.9.3. Key Financials
18.3.9.4. Sales Footprint
18.3.9.5. SWOT Analysis
18.3.9.6. Strategy Overview
18.3.9.6.1. Marketing Strategy
18.3.9.6.2. Product Strategy
18.3.9.6.3. Channel Strategy
18.3.10. Koninklijke Philips NV
18.3.10.1. Overview
18.3.10.2. Product Portfolio
18.3.10.3. Key Financials
18.3.10.4. Sales Footprint
18.3.10.5. SWOT Analysis
18.3.10.6. Strategy Overview
18.3.10.6.1. Marketing Strategy
18.3.10.6.2. Product Strategy
18.3.10.6.3. Channel Strategy
18.3.11. Fujifilm Holdings
18.3.11.1. Overview
18.3.11.2. Product Portfolio
18.3.11.3. Key Financials
18.3.11.4. Sales Footprint
18.3.11.5. SWOT Analysis
18.3.11.6. Strategy Overview
18.3.11.6.1. Marketing Strategy
18.3.11.6.2. Product Strategy
18.3.11.6.3. Channel Strategy
18.3.12. A&G Pharmaceutical, Inc.
18.3.12.1. Overview
18.3.12.2. Product Portfolio
18.3.12.3. Key Financials
18.3.12.4. Sales Footprint
18.3.12.5. SWOT Analysis
18.3.12.6. Strategy Overview
18.3.12.6.1. Marketing Strategy
18.3.12.6.2. Product Strategy
18.3.12.6.3. Channel Strategy
18.3.13. Biocrates Life Sciences AG
18.3.13.1. Overview
18.3.13.2. Product Portfolio
18.3.13.3. Key Financials
18.3.13.4. Sales Footprint
18.3.13.5. SWOT Analysis
18.3.13.6. Strategy Overview
18.3.13.6.1. Marketing Strategy
18.3.13.6.2. Product Strategy
18.3.13.6.3. Channel Strategy
18.3.14. Metabolomic Technologies, Inc.
18.3.14.1. Overview
18.3.14.2. Product Portfolio
18.3.14.3. Key Financials
18.3.14.4. Sales Footprint
18.3.14.5. SWOT Analysis
18.3.14.6. Strategy Overview
18.3.14.6.1. Marketing Strategy
18.3.14.6.2. Product Strategy
18.3.14.6.3. Channel Strategy
18.3.15. Myriad Genetics
18.3.15.1. Overview
18.3.15.2. Product Portfolio
18.3.15.3. Key Financials
18.3.15.4. Sales Footprint
18.3.15.5. SWOT Analysis
18.3.15.6. Strategy Overview
18.3.15.6.1. Marketing Strategy
18.3.15.6.2. Product Strategy
18.3.15.6.3. Channel Strategy
18.3.16. OncoCyte Corporation
18.3.16.1. Overview
18.3.16.2. Product Portfolio
18.3.16.3. Key Financials
18.3.16.4. Sales Footprint
18.3.16.5. SWOT Analysis
18.3.16.6. Strategy Overview
18.3.16.6.1. Marketing Strategy
18.3.16.6.2. Product Strategy
18.3.16.6.3. Channel Strategy
18.3.17. POC Medical Systems, Inc.
18.3.17.1. Overview
18.3.17.2. Product Portfolio
18.3.17.3. Key Financials
18.3.17.4. Sales Footprint
18.3.17.5. SWOT Analysis
18.3.17.6. Strategy Overview
18.3.17.6.1. Marketing Strategy
18.3.17.6.2. Product Strategy
18.3.17.6.3. Channel Strategy
18.3.18. Hologic, Inc.
18.3.18.1. Overview
18.3.18.2. Product Portfolio
18.3.18.3. Key Financials
18.3.18.4. Sales Footprint
18.3.18.5. SWOT Analysis
18.3.18.6. Strategy Overview
18.3.18.6.1. Marketing Strategy
18.3.18.6.2. Product Strategy
18.3.18.6.3. Channel Strategy
18.3.19. Provista Diagnostics, Inc.
18.3.19.1. Overview
18.3.19.2. Product Portfolio
18.3.19.3. Key Financials
18.3.19.4. Sales Footprint
18.3.19.5. SWOT Analysis
18.3.19.6. Strategy Overview
18.3.19.6.1. Marketing Strategy
18.3.19.6.2. Product Strategy
18.3.19.6.3. Channel Strategy
18.3.20. BioTime, Inc.
18.3.20.1. Overview
18.3.20.2. Product Portfolio
18.3.20.3. Key Financials
18.3.20.4. Sales Footprint
18.3.20.5. SWOT Analysis
18.3.20.6. Strategy Overview
18.3.20.6.1. Marketing Strategy
18.3.20.6.2. Product Strategy
18.3.20.6.3. Channel Strategy
19. Assumptions and Acronyms Used
20. Research Methodology
List of Tables
Table 01: Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Diagnostic Test Type
Table 02: Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033 by End User
Table 03: Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
Table 04: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 05: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Diagnostic Test Type
Table 06: North America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by End User
Table 07: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 08: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Diagnostic Test Type
Table 09: Latin America Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by End User
Table 10: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 11: Europe Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Diagnostic Test Type
Table 12: Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033by End User
Table 13: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 14: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Diagnostic Test Type
Table 15: East Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by End User
Table 16: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 17: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Diagnostic Test Type
Table 18: South Asia Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by End User
Table 19: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 20: Oceania Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Diagnostic Test Type
Table 21: Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033by End User
Table 22: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Country
Table 23: Middle East & Africa Market Value (US$ Million) Analysis 2017 to 2022 and Forecast 2023 to 2033, by Diagnostic Test Type
Table 24: Middle East & Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 by End User
List of Charts
Figure 01: Global Market Value (US$ Million) Analysis, 2017 to 2022
Figure 02: Global Market Forecast & Y-o-Y Growth, 2023 to 2033
Figure 03: Global Market Absolute $ Opportunity (US$ Million) Analysis, 2022–2033
Figure 04: Global Market Value Share (%) Analysis 2023 and 2033, by Diagnostic Test Type
Figure 05: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Diagnostic Test Type
Figure 06: Global Market Attractiveness Analysis 2023 to 2033, by Diagnostic Test Type
Figure 07: Global Market Value Share (%) Analysis 2023 and 2033, by End User
Figure 08: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by End User
Figure 09: Global Market Attractiveness Analysis 2023 to 2033, by End User
Figure 10: Global Market Value Share (%) Analysis 2023 and 2033, by Region
Figure 11: Global Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
Figure 12: Global Market Attractiveness Analysis 2023 to 2033, by Region
Figure 13: North America Market Value (US$ Million) Analysis, 2017 to 2022
Figure 14: North America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 15: North America Market Value Share, by Diagnostic Test Type (2023 E)
Figure 16: North America Market Value Share, by End User (2023 E)
Figure 17: North America Market Value Share, by Country (2023 E)
Figure 18: North America Market Attractiveness Analysis by Diagnostic Test Type, 2023 to 2033
Figure 19: North America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 20: U.S. Market Value Proportion Analysis, 2022
Figure 21: Global Vs. U.S. Growth Comparison
Figure 22: U.S. Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 23: U.S. Market Share Analysis (%) by End User, 2022 & 2033
Figure 24: Canada Market Value Proportion Analysis, 2022
Figure 25: Global Vs. Canada. Growth Comparison
Figure 26: Canada Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 27: Canada Market Share Analysis (%) by End User, 2022 & 2033
Figure 28: Latin America Market Value (US$ Million) Analysis, 2017 to 2022
Figure 29: Latin America Market Value (US$ Million) Forecast, 2023 to 2033
Figure 30: Latin America Market Value Share, by Diagnostic Test Type (2023 E)
Figure 31: Latin America Market Value Share, by End User (2023 E)
Figure 32: Latin America Market Value Share, by Country (2023 E)
Figure 33: Latin America Market Attractiveness Analysis by Diagnostic Test Type, 2023 to 2033
Figure 34: Latin America Market Attractiveness Analysis by End User, 2023 to 2033
Figure 35: Latin America Market Attractiveness Analysis by Country, 2023 to 2033
Figure 36: Mexico Market Value Proportion Analysis, 2022
Figure 37: Global Vs Mexico Growth Comparison
Figure 38: Mexico Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 39: Mexico Market Share Analysis (%) by End User, 2022 & 2033
Figure 40: Brazil Market Value Proportion Analysis, 2022
Figure 41: Global Vs. Brazil. Growth Comparison
Figure 42: Brazil Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 43: Brazil Market Share Analysis (%) by End User, 2022 & 2033
Figure 44: Argentina Market Value Proportion Analysis, 2022
Figure 45: Global Vs Argentina Growth Comparison
Figure 46: Argentina Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 47: Argentina Market Share Analysis (%) by End User, 2022 & 2033
Figure 48: Europe Market Value (US$ Million) Analysis, 2017 to 2022
Figure 49: Europe Market Value (US$ Million) Forecast, 2023 to 2033
Figure 50: Europe Market Value Share, by Diagnostic Test Type (2023 E)
Figure 51: Europe Market Value Share, by End User (2023 E)
Figure 52: Europe Market Value Share, by Country (2023 E)
Figure 53: Europe Market Attractiveness Analysis by Diagnostic Test Type, 2023 to 2033
Figure 54: Europe Market Attractiveness Analysis by End User, 2023 to 2033
Figure 55: Europe Market Attractiveness Analysis by Country, 2023 to 2033
Figure 56: UK Market Value Proportion Analysis, 2022
Figure 57: Global Vs. UK Growth Comparison
Figure 58: UK Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 59: UK Market Share Analysis (%) by End User, 2022 & 2033
Figure 60: Germany Market Value Proportion Analysis, 2022
Figure 61: Global Vs. Germany Growth Comparison
Figure 62: Germany Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 63: Germany Market Share Analysis (%) by End User, 2022 & 2033
Figure 64: Italy Market Value Proportion Analysis, 2022
Figure 65: Global Vs. Italy Growth Comparison
Figure 66: Italy Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 67: Italy Market Share Analysis (%) by End User, 2022 & 2033
Figure 68: France Market Value Proportion Analysis, 2022
Figure 69: Global Vs France Growth Comparison
Figure 70: France Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 71: France Market Share Analysis (%) by End User, 2022 & 2033
Figure 72: Spain Market Value Proportion Analysis, 2022
Figure 73: Global Vs Spain Growth Comparison
Figure 74: Spain Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 75: Spain Market Share Analysis (%) by End User, 2022 & 2033
Figure 76: Russia Market Value Proportion Analysis, 2022
Figure 77: Global Vs Russia Growth Comparison
Figure 78: Russia Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 79: Russia Market Share Analysis (%) by End User, 2022 & 2033
Figure 80: BENELUX Market Value Proportion Analysis, 2022
Figure 81: Global Vs BENELUX Growth Comparison
Figure 82: BENELUX Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 83: BENELUX Market Share Analysis (%) by End User, 2022 & 2033
Figure 84: East Asia Market Value (US$ Million) Analysis, 2017 to 2022
Figure 85: East Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 86: East Asia Market Value Share, by Diagnostic Test Type (2023 E)
Figure 87: East Asia Market Value Share, by End User (2023 E)
Figure 88: East Asia Market Value Share, by Country (2023 E)
Figure 89: East Asia Market Attractiveness Analysis by Diagnostic Test Type, 2023 to 2033
Figure 90: East Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 91: East Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 92: China Market Value Proportion Analysis, 2022
Figure 93: Global Vs. China Growth Comparison
Figure 94: China Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 95: China Market Share Analysis (%) by End User, 2022 & 2033
Figure 96: Japan Market Value Proportion Analysis, 2022
Figure 97: Global Vs. Japan Growth Comparison
Figure 98: Japan Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 99: Japan Market Share Analysis (%) by End User, 2022 & 2033
Figure 100: South Korea Market Value Proportion Analysis, 2022
Figure 101: Global Vs South Korea Growth Comparison
Figure 102: South Korea Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 103: South Korea Market Share Analysis (%) by End User, 2022 & 2033
Figure 104: South Asia Market Value (US$ Million) Analysis, 2017 to 2022
Figure 105: South Asia Market Value (US$ Million) Forecast, 2023 to 2033
Figure 106: South Asia Market Value Share, by Diagnostic Test Type (2023 E)
Figure 107: South Asia Market Value Share, by End User (2023 E)
Figure 108: South Asia Market Value Share, by Country (2023 E)
Figure 109: South Asia Market Attractiveness Analysis by Diagnostic Test Type, 2023 to 2033
Figure 110: South Asia Market Attractiveness Analysis by End User, 2023 to 2033
Figure 111: South Asia Market Attractiveness Analysis by Country, 2023 to 2033
Figure 112: India Market Value Proportion Analysis, 2022
Figure 113: Global Vs. India Growth Comparison
Figure 114: India Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 115: India Market Share Analysis (%) by End User, 2022 & 2033
Figure 116: Indonesia Market Value Proportion Analysis, 2022
Figure 117: Global Vs. Indonesia Growth Comparison
Figure 118: Indonesia Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 119: Indonesia Market Share Analysis (%) by End User, 2022 & 2033
Figure 120: Malaysia Market Value Proportion Analysis, 2022
Figure 121: Global Vs. Malaysia Growth Comparison
Figure 122: Malaysia Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 123: Malaysia Market Share Analysis (%) by End User, 2022 & 2033
Figure 124: Thailand Market Value Proportion Analysis, 2022
Figure 125: Global Vs. Thailand Growth Comparison
Figure 126: Thailand Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 127: Thailand Market Share Analysis (%) by End User, 2022 & 2033
Figure 128: Oceania Market Value (US$ Million) Analysis, 2017 to 2022
Figure 129: Oceania Market Value (US$ Million) Forecast, 2023 to 2033
Figure 130: Oceania Market Value Share, by Diagnostic Test Type (2023 E)
Figure 131: Oceania Market Value Share, by End User (2023 E)
Figure 132: Oceania Market Value Share, by Country (2023 E)
Figure 133: Oceania Market Attractiveness Analysis by Diagnostic Test Type, 2023 to 2033
Figure 134: Oceania Market Attractiveness Analysis by End User, 2023 to 2033
Figure 135: Oceania Market Attractiveness Analysis by Country, 2023 to 2033
Figure 136: Australia Market Value Proportion Analysis, 2022
Figure 137: Global Vs. Australia Growth Comparison
Figure 138: Australia Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 139: Australia Market Share Analysis (%) by End User, 2022 & 2033
Figure 140: New Zealand Market Value Proportion Analysis, 2022
Figure 141: Global Vs New Zealand Growth Comparison
Figure 142: New Zealand Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 143: New Zealand Market Share Analysis (%) by End User, 2022 & 2033
Figure 144: Middle East & Africa Market Value (US$ Million) Analysis, 2017 to 2022
Figure 145: Middle East & Africa Market Value (US$ Million) Forecast, 2023 to 2033
Figure 146: Middle East & Africa Market Value Share, by Diagnostic Test Type (2023 E)
Figure 147: Middle East & Africa Market Value Share, by End User (2023 E)
Figure 148: Middle East & Africa Market Value Share, by Country (2023 E)
Figure 149: Middle East & Africa Market Attractiveness Analysis by Diagnostic Test Type, 2023 to 2033
Figure 150: Middle East & Africa Market Attractiveness Analysis by End User, 2023 to 2033
Figure 151: Middle East & Africa Market Attractiveness Analysis by Country, 2023 to 2033
Figure 152: GCC Countries Market Value Proportion Analysis, 2022
Figure 153: Global Vs GCC Countries Growth Comparison
Figure 154: GCC Countries Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 155: GCC Countries Market Share Analysis (%) by End User, 2022 & 2033
Figure 156: Türkiye Market Value Proportion Analysis, 2022
Figure 157: Global Vs. Türkiye Growth Comparison
Figure 158: Türkiye Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 159: Türkiye Market Share Analysis (%) by End User, 2022 & 2033
Figure 160: South Africa Market Value Proportion Analysis, 2022
Figure 161: Global Vs. South Africa Growth Comparison
Figure 162: South Africa Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 163: South Africa Market Share Analysis (%) by End User, 2022 & 2033
Figure 164: Northern Africa Market Value Proportion Analysis, 2022
Figure 165: Global Vs Northern Africa Growth Comparison
Figure 166: Northern Africa Market Share Analysis (%) by Diagnostic Test Type, 2022 & 2033
Figure 167: Northern Africa Market Share Analysis (%) by End User, 2022 & 2033
